Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-16

FDA Approved: PRIALT — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

The FDA approved TerSera Therapeutics LLC's supplemental application for PRIALT (ziconotide acetate).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prialt (ziconotide)

Snippet

SUPPL AP for PRIALT (ZICONOTIDE ACETATE)